Loading chat...
HI SR88
Resolution
AI Summary
-
Department of Health requested to convene a Therapeutic Psilocybin Working Group to examine federal, state, and local laws regarding therapeutic psilocybin use and review medical studies on psilocybin's safety and efficacy for treating mental health conditions.
-
Working group directed to develop a long-term strategic plan contingent on FDA approval for medical use, enabling safe, accessible, and affordable therapeutic psilocybin or psilocybin-based products for adults age 21 and older.
-
Working group membership includes the Director of Health (chairperson), Attorney General, Dean of the John A. Burns School of Medicine, relevant legislative committee chairs, Hawaii State Council on Mental Health chairperson, a licensed physician or advanced practice registered nurse, and a psychiatrist.
-
Preliminary report due to Legislature no later than twenty days before the 2023 regular session convening, and final report with proposed legislation due no later than twenty days before the 2024 regular session convening.
-
Working group dissolved on July 1, 2024.
Legislative Description
Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.
Department of Health
Last Action
Certified copies of resolutions sent, 06/06/22.
6/6/2022